Dual MET and ERBB inhibition overcomes intratumor plasticity in osimertinib-resistant-advanced non-small-cell lung cancer (NSCLC)

por Martinez-Marti, A, Felip, E, Matito, J, Mereu, E, Navarro, A, Cedrés, S, Pardo, N, Martinez de Castro, A, Remon, J, Miquel, J M, Guillaumet-Adkins, A, Nadal, E, Rodriguez-Esteban, G, Arqués, O, Fasani, R, Nuciforo, P, Heyn, H, Villanueva, A, Palmer, H G, Vivancos, A
Publicado 2017

Concordance of blood- and tumor-based detection of RAS mutations to guide anti-EGFR therapy in metastatic colorectal cancer

por Grasselli, J, Elez, E, Caratù, G, Matito, J, Santos, C, Macarulla, T, Vidal, J, Garcia, M, Viéitez, J M, Paéz, D, Falcó, E, Lopez Lopez, C, Aranda, E, Jones, F, Sikri, V, Nuciforo, P, Fasani, R, Tabernero, J, Montagut, C, Azuara, D, Dienstmann, R, Salazar, R, Vivancos, A
Publicado 2017